Discover B2B companies, suppliers, and manufacturers related to this keyword category
A techbio platform company developing AI & microfluidics-based in vivo, in vitro & protein characterization solutions.
Voted Best Tech Start-up in North America (2022 Timmy Awards)
We support ambitious scientists of any nationality, driven by passion to pursue frontier research.
The new Italian research institute for Life Sciences based at the heart of MIND - Milano Innovation District.
Harnessing the collective genius of science and breaking free of established dogma to promote brain resiliency.
Laying the foundations for tomorrow's medicine
Committed to change the fate of age-related neurodegenerative diseases
Üsküdar University, cellular therapies and stem cell production, application and research center.
Brain.Research.Life
Pioneering personalized medicine in epigenetics
Helping brain researchers decipher the awake brain
Pioneering therapies for people with neurological disorders
Creating a new path for neurodegenerative diseases
Treating Neurodegenerative Disease by Restoring Autophagy
Developing a New Class of Molecular Diagnostics and Digital Biomarkers for the Eye to Diagnose & Monitor Human Diseases
Developing a new class of therapeutics for neurodegenerative and psychiatric diseases
Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.
#IRBM — powerful integrated drug discovery from concept to candidate.
Macrophage Biology Revealed:Developing breakthrough approaches to macrophage activity to change the course of disease
Neuro-Bio is a privately-owned biotech out of Oxford University with a therapeutic focus on neurodegenerative diseases.
Pioneering next-gen therapeutics to treat inflammation-driven neurodegenerative diseases and autoimmune disorders.
Smarter Molecules, Targeted Delivery, Faster to Patients.
A purpose driven biotechnology company committed to responsible research, development, and innovation.
Drug discovery for neurodegenerative diseases
Fighting Alzheimer’s by Restoring the Brain’s Innate Clearance Systems
Developing first and best-in-class neuroplastogens for diseases where neuronal connectivity is altered
Unlock biomedical research data with comprehensive bioinformatics
A global leader in bispecific antibody therapeutics for immuno-oncology and neurodegenerative diseases.